Celebrex

(Celecoxib)

ApprovedSmall molecule

Celecoxib is used to reduce pain and inflammation from conditions like arthritis, menstrual cramps, and other painful conditions. It works by reducing substances in the body that cause inflammation and pain.[2] Celebrex is currently approved and in use across 101 indications[4].[1]

Celebrex is one of 1293 small molecule programs targeting COVID-19. It is currently in Approved.

101

Indications

413

Total Trials

Active Trials

1,292

Competitors

FDA Applications

NDA/BLA/ANDA regulatory filings

Patents

Pipeline

Status by Indication[4][1]

Indication

COVID-19Withdrawn

ChemotherapyRecruiting

Facial PainApproved

Endometrial CancerApproved

Anti-Neutrophil Antibody Associated VasculitisApproved

Breast NeoplasmApproved

Colonic NeoplasmApproved

ToothacheApproved

TonsillitisApproved

Central Nervous System NeoplasmApproved

COVID-19Phase 2

Withdrawn

ChemotherapyPhase 2

Recruiting

Facial PainApproved

Approved

Endometrial CancerApproved

Approved

Anti-Neutrophil Antibody Associated VasculitisApproved

Approved

Breast NeoplasmApproved

Approved

Colonic NeoplasmApproved

Approved

ToothacheApproved

Approved

TonsillitisApproved

Approved

Central Nervous System NeoplasmApproved

Approved

Showing 10 of 100 indications

Competition

Competitive Landscape

317 competitors in COVID-19

#DrugCompanyPhaseTrials

Celebrex

PPhiladelphia Eye Associates

Approved

4 2

Activella

Benadryl

1 4

Glucocorticoid

AbbVie

Preclinical

1 5

Achromycin V

WWyeth-Lederle Vaccines

SARS-COV-2 VACCINE

2 7

Vit D

PPost Graduate Institute of Medical Education and Research, Chandigarh

Preclinical

1 8

Blood Taken

HHospices Civils de Lyon

Preclinical

1 9

Aprotinin

Bayer

Preclinical

1 10

Sivelestat Sodium

TThe First Hospital of Jilin University

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2026

Phase 2Recruiting

Locally-Advanced Rectal Cancer

NCT05731726

Phase 1Active, not recruiting

Myeloproliferative Neoplasm

NCT04041050

Q4 2027

Phase 2Recruiting

Liver Cancer

NCT07174570

Phase 2Recruiting

Epilepsy

NCT05637086

Phase 2Recruiting

Intracerebral Hemorrhage

NCT05434065

Q1 2028

Post-ApprovalRecruiting

Osteoarthritis

NCT06245109

Clinical

Trials by Indication[1]

Osteoarthritis19 trials

NSAID Treatment in Knee Osteoarthritis

Completed·UUniversity of Catanzaro·Phase 4·NCT01860833·90 enrolled

Phase III Study of CG100649 in Osteoarthritis Patients

Completed·CCrystalGenomics, Inc.·Phase 3·NCT01765296·362 enrolled

Safety and Efficacy of Two Dosages of Diractin® in Osteoarthritis (OA)

Completed·IIDEA AG·Phase 3·NCT00716547·1,399 enrolled

Show 16 more trials

Efficacy and Safety of Celecoxib Versus Placebo in the Treatment of Patients With Osteoarthritis of the Knee Who Were Unresponsive to Naproxen and Ibuprofen

Completed·PPfizer's Upjohn has merged with Mylan to form Viatris Inc.·Phase 4·NCT00640627·380 enrolled

Efficacy of Celecoxib 200mg in Relieving Pain and Walking Dysfunction in Osteoarthritis of the Knee

Unknown status·UUniversity Hospitals Cleveland Medical Center·Phase 2·NCT00597415·30 enrolled

A Study of LY2951742 in Participants With Mild to Moderate Osteoarthritis Knee Pain

Terminated· Eli Lilly logo

Eli Lilly·Phase 2·NCT02192190·268 enrolled

A Clinical Trial of YH23537 in Patients With Knee Osteoarthritis

Completed·YYuhan Corporation·Phase 2·NCT02759198·456 enrolled

Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (Europe)

Completed·PPfizer's Upjohn has merged with Mylan to form Viatris Inc.·Phase 4·NCT00630929·388 enrolled

Measuring Gait And Self-Reported Pain In Patients With Osteoarthritis Of The Knee Using Placebo/Oxycodone/Celecoxib.

Terminated· Pfizer logo

Pfizer·Phase 4·NCT00484718·6 enrolled

Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis

Recruiting·NNorthwestern University·Phase 4·NCT06245109·180 enrolled

Efficacy and Mechanism of FSN Treatment for Senile Knee Osteoarthritis

Not yet recruiting·GGuangdong Provincial Hospital of Traditional Chinese Medicine·N/A·NCT06328153·60 enrolled

Efficacy and Safety of Celecoxib/Acetaminophen Versus Celecoxib for Diagnosed Osteoarthritis in Acute Exacerbation

Recruiting·LLaboratorios Silanes S.A. de C.V.·Phase 3·NCT06863636·231 enrolled

Clinical Trial of YYC301 for Treatment of Osteoarthritis of the Knee

Completed·YYooyoung Pharmaceutical Co., Ltd.·Phase 2·NCT03850587·261 enrolled

Gastro-protective Effect and Pain Relief Effect of Naxozol Compared to Celecoxib in Patients With Osteoarthritis

Unknown status·SSeverance Hospital·Phase 4·NCT02355236·106 enrolled

Safety and Efficacy of Etoricoxib 30 mg Versus Celecoxib 200 mg in Korean Participants With Osteoarthritis

Completed·OOrganon and Co·Phase 3·NCT01554163·239 enrolled

A Phase Ib Study to Evaluate the Efficacy and Safety of HRS-2129 in Patients With Knee Osteoarthritis

Recruiting·SShandong Suncadia Medicine Co., Ltd.·Phase 1·NCT07351968·200 enrolled

Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis

Completed·JJiangsu XinChen-Techfields Pharma Co., LTD.·Phase 3·NCT05324163·180 enrolled

Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and Hip

Terminated· Regeneron logo

Regeneron·Phase 2·NCT03949673·23 enrolled

The Study to Evaluate Efficacy and Safety of Celecoxib Capsule in Hand Osteoarthritis Patients

Completed· Chong Kun Dang Pharmaceutical logo

Chong Kun Dang Pharmaceutical·Phase 4·NCT03067194·117 enrolled

Celecoxib14 trials

An Open-Label Study Of Celecoxib In Patients With Posttraumatic Pain

Completed·PPfizer's Upjohn has merged with Mylan to form Viatris Inc.·Phase 3·NCT00976716·80 enrolled

ATRA, Celecoxib, and Itraconazole as Maintenance

Completed·UUniversity of Iowa·Phase 1·NCT02401295·1 enrolled

Phase I Study to Evaluate Bioavailability of Overencapsulated Celecoxib

Completed·PPOZEN·Phase 1·NCT00729495·80 enrolled

Show 11 more trials

Adjunctive Celecoxib in Childhood-onset OCD Study

Unknown status·UUniversity of British Columbia·Phase 2·NCT04673578·80 enrolled

Effect of AKB-6548 on the Pharmacokinetics of Celecoxib

Completed·AAkebia Therapeutics·Phase 1·NCT02502500·12 enrolled

Study of Celecoxib Bioavailability in Healthy Subjects

Completed·PPfizer's Upjohn has merged with Mylan to form Viatris Inc.·Phase 1·NCT00296127·24 enrolled

Comparison of Small Bowel Lesions Associated With Celecoxib Versus Ibuprofen Plus Omeprazole

Completed·PPfizer's Upjohn has merged with Mylan to form Viatris Inc.·Phase 4·NCT00640809·408 enrolled

A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer

Completed·—·Phase 2·NCT00165451·20 enrolled

Evaluation of Post-Procedure Administration of Celecoxib Following Shoulder Surgery

Unknown status·SSt. Louis Joint Replacement Institute·Phase 4·NCT03305068·150 enrolled

GI-Reasons- A Trial Of GI Safety Of Celecoxib Compared With Non-Selective Nonsteroidal Antiinflammatory Drugs (NSAIDS)

Completed·PPfizer's Upjohn has merged with Mylan to form Viatris Inc.·Phase 4·NCT00373685·8,067 enrolled

Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy

Withdrawn·NNational Cancer Institute (NCI)·Phase 1·NCT02839694

Celecoxib Versus Hyoscine Butyl-bromide in Reducing Pain Associated With IUD.

Completed·—·N/A·NCT03499743·105 enrolled

Celecoxib in Colposcopic Directed Biopsy

Completed·—·Phase 4·NCT03464552·170 enrolled

Bioequivalence Study of Generic Celecoxib 200 mg Capsules

Not yet recruiting·IInternational Bio service·Phase 1·NCT06337422·40 enrolled

Non-Small Cell Lung Cancer10 trials

Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Completed·JJonsson Comprehensive Cancer Center·Phase 1·NCT00104767·7 enrolled

Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer

Completed·AAlliance for Clinical Trials in Oncology·Phase 2·NCT00070486·140 enrolled

Celecoxib and Erlotinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Completed·NNational Cancer Institute (NCI)·Phase 1·NCT00088959·45 enrolled

Show 7 more trials

Cisplatin/Etoposide and Concurrent Radiotherapy With or Without Celecoxib in Patients With Unresectable Locally Advanced Non-small Cell Lung Cancer (NSCLC)

Unknown status·CChinese Academy of Medical Sciences·Phase 2·NCT01503385·100 enrolled

Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer

Completed·NNorthwestern University·Phase 2·NCT00058006

Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer

Completed·VVanderbilt-Ingram Cancer Center·N/A·NCT00653250·22 enrolled

Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer

Completed·JJonsson Comprehensive Cancer Center·Phase 2·NCT00062179·7 enrolled

Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer

Completed·—·Phase 2·NCT00499655·107 enrolled

Effect of Celecoxib on Survival in Patients With Advanced Non-Small Cell Lung Cancer Receiving Chemotherapy

Unknown status·UUniversity Hospital, Linkoeping·Phase 3·NCT00300729·319 enrolled

Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer

Completed·NNorthwestern University·Phase 1/2·NCT00073866

Breast Cancer7 trials

Vinorelbine and Celecoxib in Treating Women With Relapsed or Metastatic Breast Cancer

Terminated·—·Phase 1·NCT00075673·6 enrolled

Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery

Terminated·UUniversity of Nebraska·Phase 2·NCT00665457·3 enrolled

Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer

Terminated·AAlliance for Clinical Trials in Oncology·Phase 2·NCT00045591·39 enrolled

Show 4 more trials

European Celecoxib Trial in Primary Breast Cancer

Completed·IImperial College London·Phase 3·NCT02429427·2,639 enrolled

Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer

Completed·OOhio State University Comprehensive Cancer Center·Phase 2·NCT00201773·22 enrolled

S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women

Terminated·SSWOG Cancer Research Network·Phase 2·NCT00088972·8 enrolled

Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer

Completed·NNational Cancer Institute (NCI)·Phase 1·NCT00070057·75 enrolled

Total Knee Arthroplasty5 trials

Celebrex Total Knee Arthroplasty Study

Terminated·PPfizer's Upjohn has merged with Mylan to form Viatris Inc.·Phase 4·NCT00359151·22 enrolled

Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) Regimen

Completed·HHeron Therapeutics·Phase 3·NCT03974932·116 enrolled

MUA to Treat Postoperative Stiffness After Total Knee Arthroplasty

Completed·MMayo Clinic·Phase 4·NCT02739035·130 enrolled

Show 2 more trials

Peri-Articular-Multimodal Drug and Oral Celecoxib in Management of Postoperative Pain of Total Knee Arthroplasty

Completed·IIsfahan University of Medical Sciences·Phase 2·NCT05324995·146 enrolled

Pregabalin, Celecoxib, Total Knee Arthroplasty and Intrathecal Morphine

Completed·—·Phase 4·NCT01344213·100 enrolled

109 more indications

Colorectal Cancer5 trials

Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps

Completed·NNational Cancer Institute (NCI)·Phase 3·NCT00005094·1,170 enrolled

Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and Carriers

Completed·NNational Cancer Institute (NCI)·Phase 1·NCT00001693·20 enrolled

Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver

Completed·RRoswell Park Cancer Institute·Phase 2·NCT03403634·19 enrolled

Show 2 more trials

Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers

Completed·MM.D. Anderson Cancer Center·Phase 2·NCT00503035·51 enrolled

Possible Protective Effect of Celecoxib Against Capecitabine Induced Hand and Foot Syndrome in Patients With Colorectal Cancer

Unknown status·TTanta University·Phase 3·NCT05327751·44 enrolled

Prostate Cancer3 trials

A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer

Unknown status·DDepartment of Veterans Affairs, New Jersey·Phase 2·NCT00218205·28 enrolled

Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy

Terminated·UUNC Lineberger Comprehensive Cancer Center·Phase 2·NCT00073970·37 enrolled

Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer

Completed·RRutgers, The State University of New Jersey·Phase 2·NCT01220973·27 enrolled

Ankylosing Spondylitis3 trials

NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage in Ankylosing Spondylitis

Completed·—·Phase 4·NCT02758782·156 enrolled

Dose Reduction of Etanercept in Patients With Ankylosing Spondylitis

Unknown status·ZZhixiang Huang·Phase 4·NCT02638896·100 enrolled

Study Of Celecoxib Or Diclofenac For Efficacy and Safety In Chinese Patients With Ankylosing Spondylitis

Completed·PPfizer's Upjohn has merged with Mylan to form Viatris Inc.·Phase 3·NCT00762463·240 enrolled

Lung Cancer3 trials

Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer

Terminated·MM.D. Anderson Cancer Center·Phase 2·NCT00527982·1 enrolled

Celecoxib Treatment for Lung Cancer

Withdrawn·UUS Department of Veterans Affairs·Phase 1·NCT00108186

Celecoxib in Preventing Lung Cancer in Former Heavy Smokers

Completed·UUniversity of California, Los Angeles·Phase 2·NCT00055978·112 enrolled

Familial adenomatous polyposis3 trials

Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients

Terminated· Pfizer logo

Pfizer··NCT00151476·68 enrolled

Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis

Completed·MM.D. Anderson Cancer Center·Phase 1·NCT00685568·22 enrolled

Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)

Terminated·PPfizer's Upjohn has merged with Mylan to form Viatris Inc.·Phase 3·NCT00585312·106 enrolled

Interaction3 trials

A Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Potential of CCX168 With Concomitant Medications

Completed· Amgen logo

Amgen·Phase 1·NCT06004947·32 enrolled

The Pharmacokinetic Interaction Between Celecoxib and Rebamipide

Completed·HHanlim Pharm. Co., Ltd.·Phase 1·NCT01549743·30 enrolled

Drug-drug Interaction Between DWP14012 and Three Different Kinds of NSAIDs

Unknown status· Daewoong Pharmaceutical Co. LTD. logo

Daewoong Pharmaceutical Co. LTD.·Phase 1·NCT04490434·110 enrolled

Metastatic Colorectal Cancer3 trials

A Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With Metastatic Colorectal Cancer

Terminated·UUniversity of Washington·Phase 2·NCT01729923·27 enrolled

Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer

Completed·EEuropean Organisation for Research and Treatment of Cancer - EORTC·Phase 3·NCT00064181·86 enrolled

Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

Unknown status·GGERCOR - Multidisciplinary Oncology Cooperative Group·Phase 2·NCT00072553

Effectiveness3 trials

Effectiveness and Safety of Different Doses of BI 1026706 in Patients With Postoperative Dental Pain

Completed· Boehringer Ingelheim logo

Boehringer Ingelheim·Phase 1·NCT02084511·80 enrolled

Testing The Effectiveness Of Celecoxib In Patients With Painful Sore Throat

Completed·PPfizer's Upjohn has merged with Mylan to form Viatris Inc.·Phase 3·NCT00402987·269 enrolled

Effectiveness of Yunnan Baiyao in Improving Fracture Pain

Unknown status·PPeking University Third Hospital·N/A·NCT05765747·58 enrolled

Pancreatic Cancer3 trials

Celecoxib, Irinotecan and Concurrent Radiotherapy in Preoperative Pancreatic Cancer

Terminated·UUniversity of Pittsburgh·Phase 1·NCT00177853·23 enrolled

Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer

Completed·UUniversity of Michigan Rogel Cancer Center·Phase 2·NCT00176813·5 enrolled

Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer

Completed·MM.D. Anderson Cancer Center·Phase 2·NCT00068432·28 enrolled

Low back pain3 trials

Safety And Efficacy Of Celecoxib Versus Sodium Diclofenac In The Treatment Of Acute Low Back Pain

Completed·PPfizer's Upjohn has merged with Mylan to form Viatris Inc.·Phase 4·NCT00640432·244 enrolled

Radial Extracorporeal Shock Wave Therapy for Chronic Non-specific Low Back Pain

Completed·FFirst Affiliated Hospital of Zhejiang University·N/A·NCT03337607·150 enrolled

Long Term Safety and Efficacy Study of Tanezumab in Japanese Adult Subjects With Chronic Low Back Pain

Completed· Pfizer logo

Pfizer·Phase 3·NCT02725411·277 enrolled

Esophageal Cancer2 trials

Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer

Completed·—·Phase 2·NCT00137852·35 enrolled

Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal Cancer

Completed·UUNC Lineberger Comprehensive Cancer Center·Phase 2·NCT00520091·14 enrolled

Treatment2 trials

Condrosulf vs Celebrex vs Placebo in the Treatment of Knee OA

Completed·IIBSA Institut Biochimique SA·Phase 3·NCT02079727·604 enrolled

Evaluation of Clinical Efficacy of Herbal Compound in the Treatment of NSLBP

Completed·ZZhejiang Provincial Tongde Hospital·Phase 4·NCT06336993·71 enrolled

Bladder Cancer2 trials

Celecoxib for the Treatment of Non-muscle Invasive Bladder Cancer

Completed·AAzienda Ospedaliero-Universitaria Consorziale Policlinico di Bari·Phase 2·NCT02343614·58 enrolled

Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer

Completed·—·Phase 1·NCT02885974·22 enrolled

Metabolism2 trials

Phase 1 Study of ALXN1840 on the Metabolism of a CYP2C9 Substrate in Healthy Participants.

Completed· AstraZeneca logo

AstraZeneca·Phase 1·NCT04526197·36 enrolled

The Effects of NSAIDs on Bone Metabolism Following Exercise

Completed·—·Phase 1·NCT05512013·12 enrolled

Liver Cancer2 trials

Celecoxib and Erlotinib in Treating Patients With Liver Cancer

Withdrawn·UUniversity of California, San Francisco·Phase 1/2·NCT00293436

Celecoxib, Durvalumab and Tremelimumab for the Treatment of Patients With Advanced or Metastatic Liver Cancer

Recruiting·EEmory University·Phase 2·NCT07174570·39 enrolled

Chemotherapy2 trials

Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors

Recruiting·EEmory University·Phase 2·NCT04469530·55 enrolled

Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors

Active, not recruiting·EEmory University·Phase 2·NCT02574728·46 enrolled

Schizophrenia2 trials

Efficacy and Safety of Celecoxib as Add-on Therapy to Risperidone Versus Risperidone Alone in Patients With Schizophrenia

Completed· Pfizer logo

Pfizer·Phase 2·NCT00639483·270 enrolled

Anti-inflammatories and Adolescent Schizophrenia

Unknown status·HHospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico·Phase 4·NCT04020588·90 enrolled

Multimodal Analgesia2 trials

Impact of Preoperative Opioid-free Multimodal Analgesia on Time to Trial of Void in Ambulatory Urogynecologic Surgeries

Recruiting·NNorthwell Health·Phase 4·NCT06379425·70 enrolled

PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery

Completed·WWashington University School of Medicine·Phase 2·NCT03084536·134 enrolled

Acetaminophen2 trials

CI(R)CA : Coumadin Interaction With Rofecoxib, Celecoxib and Acetaminophen

Completed·HHospital Universitario Pedro Ernesto·N/A·NCT01762891·22 enrolled

Celecoxib vs. Acetaminophen/Codeine/Caffeine for Post-operative Analgesia in Rhinoplasty.

Unknown status·BBlake Raggio·Phase 4·NCT04259333·60 enrolled

Head and Neck Cancer2 trials

Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery

Unknown status·—·Phase 1/2·NCT00357617·24 enrolled

Radiosensitization With Celecoxib and Chemoradiation for Head and Neck Cancer

Completed·UUniversity of Alabama at Birmingham·Phase 1/2·NCT00581971·30 enrolled

Post Operative Pain2 trials

Perioperative Use of a Selective COX2 Inhibitor in Patients Undergoing Elective Colorectal Surgery: the Effect on Post-operative Bowel Motility and Post-operative Pain

Unknown status·SSheba Medical Center·N/A·NCT02790203·100 enrolled

Toradol v. Celecoxib for Postoperative Pain

Completed·—·Phase 2·NCT03331315·170 enrolled

Pain Control2 trials

A Selective COX-2 Inhibitor Provides Pain Control But Hinders Healing Following Arthroscopic Rotator Cuff Repair

Completed·SSeoul National University Bundang Hospital·Phase 4·NCT02850211·180 enrolled

Parecoxib Versus Celecoxib Versus Oxycodone in Pain Control for Transcatheter Chemoembolization Procedure

Completed·SSun Yat-sen University·Phase 3·NCT03059238·213 enrolled

Malignancies2 trials

Adjuvant Tumor Lysate Vaccine and Iscomatrix With or Without Metronomic Oral Cyclophosphamide and Celecoxib in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or Mediastinum

Terminated·NNational Cancer Institute (NCI)·Phase 1/2·NCT02054104·21 enrolled

Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies

Completed·NNational Cancer Institute (NCI)·Phase 1·NCT00037817·34 enrolled

Aspirin2 trials

Timed Aspirin Chronobiome Study

Not yet recruiting·UUniversity of Pennsylvania·Phase 1·NCT03590821·60 enrolled

NSAIDs vs. Coxibs in the Presence of Aspirin

Recruiting·IInova Health Care Services·Phase 4·NCT03699293·30 enrolled

Diclofenac1 trial

Study of Diclofenac Capsules to Treat Pain Following Bunionectomy

Completed·IIroko Pharmaceuticals, LLC·Phase 3·NCT01462435·428 enrolled

Myeloproliferative Neoplasm1 trial

A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm

Active, not recruiting· AbbVie logo

AbbVie·Phase 1·NCT04041050·85 enrolled

Hysterectomy1 trial

Single Dose Preoperative Gabapentin Use in Minimally Invasive Hysterectomy for Acute Pain Management

Completed·CChristiana Care Health Services·Phase 4·NCT02703259·137 enrolled

Benign Prostatic Hyperplasia1 trial

The Clinical Efficacy of Non-steroidal Anti-inflammation Drugs in Patients With Benign Prostatic Hyperplasia

Withdrawn·SSamsung Medical Center·Phase 4·NCT00687388

Colorectal1 trial

Celecoxib in Preventing Cancer in Patients With Rectal Polyps or Colorectal Neoplasia

Completed·NNational Cancer Institute (NCI)·Phase 2·NCT00043043

Tuberculosis1 trial

Evaluating Celecoxib Activity in Mycobacterium Tuberculosis: A Whole Blood Bactericidal Activity Study in Healthy Volunteers

Completed·NNational University Hospital, Singapore·Phase 1·NCT02602509·18 enrolled

Hysteroscopy1 trial

Tramadol Versus Celecoxib for Reducing Pain in Outpatient Hysteroscopy

Completed·—·Phase 2·NCT02071303·210 enrolled

Locally Advanced1 trial

COX-2 Inhibitor With Concurrent Chemoradiation in Locally Advanced Head & Neck Carcinoma

Unknown status·TTehran University of Medical Sciences·Phase 3·NCT00603759·122 enrolled

Glioblastoma1 trial

A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma

Completed·UUniversity of Ulm·Phase 1/2·NCT02770378·10 enrolled

Observational Study1 trial

Celecoxib Japan Observational Study for the Patients With Acute Pain

Completed· Astellas logo

Astellas··NCT01876121·784 enrolled

Germ Cell Tumor1 trial

Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or Mediastinum

Terminated·NNational Cancer Institute (NCI)·Phase 1·NCT01313429·19 enrolled

Opioid Analgesia1 trial

Nonopioid Analgesia After Labral Surgery

Recruiting·HHenry Ford Health System·Phase 2/3·NCT03825809·100 enrolled

Glioblastoma Multiforme1 trial

Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme

Completed·MM.D. Anderson Cancer Center·Phase 2·NCT00112502·178 enrolled

Newly Diagnosed1 trial

Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT

Terminated·SSidney Kimmel Comprehensive Cancer Center at Johns Hopkins·Phase 2·NCT00068770·35 enrolled

Antiplatelet1 trial

The Effect of Celecoxib on the Antiplatelet Effect of Aspirin and Clopidogrel in Normal Volunteers

Completed·SSeoul National University Hospital·Phase 4·NCT00882388·40 enrolled

Premalignant Lesion1 trial

Chemoprevention of Oral Premalignant Lesions

Completed· Pfizer logo

Pfizer·Phase 2·NCT00036283·42 enrolled

Tics1 trial

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Food Effect and DDI of Ascending Doses of the MEK Inhibitor Zapnometinib

Completed·AAtriva Therapeutics GmbH·Phase 1·NCT05555823·96 enrolled

Malignant Glioma1 trial

Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma

Completed·—·Phase 2·NCT00047281

ART1 trial

A Multiple Dose Study of LY3023703 in Healthy Participants

Completed· Eli Lilly logo

Eli Lilly·Phase 1·NCT01849055·48 enrolled

Pain1 trial

A Study of LY3023703 Testing Pain Relief After Wisdom Teeth Removal

Completed· Eli Lilly logo

Eli Lilly·Phase 2·NCT01872910·124 enrolled

Ewing's Sarcoma1 trial

Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors

Completed·CChildren's Oncology Group·Phase 2·NCT00061893·38 enrolled

Weight loss1 trial

Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer

Withdrawn·EEastern Cooperative Oncology Group·N/A·NCT00093678

Primary Peritoneal Cancer1 trial

Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Completed·—·Phase 2·NCT00538031·52 enrolled

Inflammatory Response1 trial

Effect of Celecoxib on Perioperative Inflammatory Response in Colon Cancer

Terminated·SStanford University·N/A·NCT01284504·1 enrolled

Uterine Cancer1 trial

A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers

Terminated·—·Phase 2·NCT00231829·23 enrolled

Bunion1 trial

Open-Label CA-008 (Vocacapsaicin) in Bunionectomy

Completed·CConcentric Analgesics·Phase 2·NCT03885596·36 enrolled

Completed·—·Phase 2·NCT02484664·12 enrolled

Ankle Injuries1 trial

Correlation Between Acute Analgesia and Long-Term Function Following Ankle Injuries

Completed·CCanadian Department of National Defence·Phase 4·NCT02667730·168 enrolled

Tonsillectomy1 trial

Celecoxib After Tonsillectomy

Completed·—·Phase 2·NCT02934191·172 enrolled

Preeclampsia1 trial

Clinical Trial of a COX-2 Inhibitor for the Treatment of Women With Preeclampsia

Withdrawn·VVirginia Commonwealth University·Phase 2·NCT00442676

Sunburn1 trial

Celecoxib in Decreasing the Damaging Effects of Sunburn in Healthy Volunteers

Completed·NNational Cancer Institute (NCI)·Phase 2·NCT02090933·25 enrolled

Inflammation1 trial

Arthroplasty Inflammation Prophylaxis With Celecoxib

Unknown status·ZZanbilowicz, Adam, DPM MS·N/A·NCT00533247·200 enrolled

Head and Neck Squamous Cell Carcinoma1 trial

Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell Carcinoma

Completed·MMemorial Sloan Kettering Cancer Center·N/A·NCT00596219·12 enrolled

Oral Mucositis1 trial

Cox-2 Inhibition in Radiation-induced Oral Mucositis

Completed·UUConn Health·Phase 2·NCT00698204·43 enrolled

Basal Cell Carcinoma1 trial

Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome

Completed·UUniversity of California, San Francisco·Phase 2·NCT00023621·60 enrolled

Arthroscopy1 trial

Evaluation of Perioperative Celecoxib for Hip Arthroscopy

Completed·NNorthwestern University·N/A·NCT02779166·98 enrolled

Ovarian Epithelial Cancer1 trial

Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy

Withdrawn·UUniversity of Alabama at Birmingham·N/A·NCT00084370

COVID-191 trial

Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)

Withdrawn·LLeidos Life Sciences·Phase 2·NCT05085574

Multiple Sclerosis1 trial

PET Imaging of Cyclooxygenase in Multiple Sclerosis

Terminated·NNational Institute of Mental Health (NIMH)·Phase 2·NCT05062083·7 enrolled

Bipolar Depression1 trial

Cyclooxygenase-2-Inhibitor Combination Treatment for Bipolar Depression

Completed·LLoyola University·Phase 4·NCT01479829·100 enrolled

Squamous Intraepithelial Lesions of the Cervix1 trial

S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix

Withdrawn·SSWOG Cancer Research Network·Phase 2·NCT00072540

Influenza1 trial

Treatment of Severe Influenza A Infection

Completed·TThe University of Hong Kong·Phase 3·NCT02108366·107 enrolled

Trial1 trial

Stony Brook Medicine Anti-Inflammatory Trial

Not yet recruiting·SStony Brook University·Phase 4·NCT06699966·42 enrolled

Vitamin D1 trial

Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity

Completed·VVA Office of Research and Development·Phase 1/2·NCT00953849·21 enrolled

Metastasis1 trial

Vaccine Therapy and Radiation to Liver Metastasis in Patients With CEA-Positive Solid Tumors

Completed·NNational Cancer Institute (NCI)·Phase 1·NCT00081848·12 enrolled

Cystectomy1 trial

Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder

Withdrawn·FFox Chase Cancer Center·N/A·NCT00084578

LAM1 trial

Window of Opportunity Study Targeting the Inflammatory Milieu

Completed·UUniversity of Colorado, Denver·Phase 1·NCT01881048·42 enrolled

Temporomandibular Disorders1 trial

Study of Etanercept and Celecoxib to Treat Temporomandibular Disorders (Painful Joint Conditions)

Completed·NNational Institute of Dental and Craniofacial Research (NIDCR)·Phase 2·NCT00001955·150 enrolled

Advanced Cancer1 trial

Etoposide and Celecoxib in Patients With Advanced Cancer

Completed·—·Phase 1·NCT00551005·58 enrolled

Adenocarcinoma1 trial

Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon

Completed·EEuropean Organisation for Research and Treatment of Cancer - EORTC·Phase 3·NCT00085163

Single Dose1 trial

A Single Dose Study of LY3023703 in Healthy Participants

Completed· Eli Lilly logo

Eli Lilly·Phase 1·NCT01632579·30 enrolled

Elective1 trial

Statins and Selective Cyclooxygenase-2 Receptor Inhibitors in Blunt Chest Trauma

Unknown status·TTel-Aviv Sourasky Medical Center·N/A·NCT01623921·100 enrolled

Enhanced Recovery After Surgery1 trial

Comparison of Postoperative Pain Management in Patients Undergoing Laparoscopic Colorectal Surgery Under Enhanced Recovery After Surgery (ERAS) Program, Laparoscopic Colorectal Surgery Without ERAS and Open Colorectal Surgery

Unknown status·PPrince of Songkla University··NCT04997174·162 enrolled

Arthritis1 trial

Chinese Spondyloarthritis Inception Cohort (CESPIC)

Not yet recruiting·SSouthwest Hospital, China··NCT05960864·1,000 enrolled

Knee Surgery1 trial

Effect of Celecoxib Versus Placebo Before and After Knee Surgery on Overall Use of Analgesics After Surgery

Completed·PPfizer's Upjohn has merged with Mylan to form Viatris Inc.·Phase 4·NCT00633438·204 enrolled

Non-steroidal Anti-inflammatory Drugs1 trial

Variability in Response to Non-steroidal Anti-inflammatory Drugs

Terminated·UUniversity of Pennsylvania·Phase 1·NCT02502006·16 enrolled

Colorectal Surgery1 trial

Early Diuresis Following Colorectal Surgery

Completed·MMayo Clinic·Phase 4·NCT02351934·123 enrolled

Colorectal Adenoma1 trial

Evaluation of Surgically Resected Colorectal Adenomas and Carcinomas After 7 Days Pretreatment With Celecoxib

Completed·UUniversity of Alabama at Birmingham·Phase 2·NCT00582660·40 enrolled

Hepatocellular Carcinoma1 trial

Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma

Completed·NNorthwestern University·Phase 1/2·NCT00057980·8 enrolled

Locally-advanced Rectal Cancer1 trial

Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer

Recruiting·ZZhejiang University·Phase 2·NCT05731726·50 enrolled

Major Depressive Disorder1 trial

INflammation-based Stratification for Immune-Targeted Augmentation in Major Depressive Disorder

Recruiting·UUniversiteit Antwerpen·Phase 3·NCT05644301·240 enrolled

Acute Dental Pain1 trial

Preemptive Analgesia With Celecoxib for Acute Dental Pain Management

Completed·TThe University of Texas Health Science Center, Houston·Phase 4·NCT04790812·65 enrolled

Depression1 trial

Treating Immuno-metabolic Depression With Anti-inflammatory Drugs

Recruiting·AAmsterdam UMC, location VUmc·Phase 3·NCT05415397·140 enrolled

Pain Threshold1 trial

Experimental Biomarker Study for Pain Thresholds

Completed·PPurdue Pharma LP·Phase 1·NCT02695745·37 enrolled

Indomethacin1 trial

Phase 2 Study of Indomethacin Capsules to Treat Dental Pain

Completed·IIroko Pharmaceuticals, LLC·Phase 2·NCT00964431·203 enrolled

Malignant Pleural Mesothelioma1 trial

Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma

Active, not recruiting·FFerring Ventures Limited·Phase 3·NCT03710876·53 enrolled

Percutaneous Coronary Intervention1 trial

Effects of Celecoxib After Percutaneous Coronary Intervention

Completed·SSeoul National University Hospital·Phase 4·NCT00292721·260 enrolled

Dental Pain1 trial

Study of Diclofenac Capsules to Treat Dental Pain

Completed·IIroko Pharmaceuticals, LLC·Phase 2·NCT00985439·202 enrolled

Radius Fracture1 trial

Celecoxib in Postoperative Analgesia for Radius Fracture Surgery

Completed·—·Phase 4·NCT05288374·42 enrolled

Epilepsy1 trial

Clinical Study Evaluating Safety of Pentoxifylline and Celecoxib in Patients With Grand-Mal Epilepsy Treated by Phenytoin Monotherapy

Recruiting·MMostafa Bahaa·Phase 2·NCT05637086·90 enrolled

Efficacy1 trial

Study of Safety, Efficacy of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3007

Completed· Johnson & Johnson logo

Johnson & Johnson·Phase 3·NCT02301234·111 enrolled

Immune1 trial

Photodynamic Therapy-Induced Immune Modulation: Part III

Terminated·WWright State University·Phase 1·NCT03643744·12 enrolled

Analgesia1 trial

Oral Tramadol Versus Oral Celecoxib for Post-perineal Repair Analgesia

Unknown status·—·Phase 4·NCT03694873·200 enrolled

Shoulder Arthroplasty1 trial

Multimodal Analgesia in Shoulder Arthroplasty

Withdrawn·RRush University Medical Center·Phase 3·NCT03586934

Peutz-Jeghers syndrome1 trial

Celecoxib for Prevention of Progression in Peutz-Jeghers Syndrome

Recruiting·—·N/A·NCT06722534·80 enrolled

Endometrial Carcinoma1 trial

Neoadjuvant Celecoxib in Newly Diagnosed Patients With Endometrial Carcinoma

Unknown status·CCliniques universitaires Saint-Luc- Université Catholique de Louvain·Phase 2·NCT03896113·48 enrolled

Montelukast1 trial

Effect of Pineapple Juice on the Pharmacokinetics of Celecoxib and Montelukast in Humans

Completed·—·Phase 2·NCT04374981·24 enrolled

Neuroinflammation1 trial

The Effect of Celecoxib on Neuroinflammation in MDD

Active, not recruiting·SStony Brook University·Phase 4·NCT04814355·42 enrolled

Solid Tumors1 trial

An Open Label Phase II Study Combining Nivolumab and Celecoxib in Patients With Advanced " Cold " Solid Tumors

Unknown status·CCliniques universitaires Saint-Luc- Université Catholique de Louvain·Phase 2·NCT03864575·68 enrolled

Immune Checkpoint Inhibition1 trial

Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer

Recruiting·TThe Netherlands Cancer Institute·Phase 2·NCT03026140·353 enrolled

Intracerebral Hemorrhage1 trial

Effects and Mechanisms of Celecoxib on Intracerebral Hemorrhage

Recruiting·NNational Taiwan University Hospital·Phase 2·NCT05434065·60 enrolled

Gait Analysis1 trial

Shengyu Decoction and Lijin Manipulation for Knee OA: 3D Gait Analysis

Enrolling by invitation·XXuhui Central Hospital, Shanghai·Phase 1·NCT06451783·94 enrolled

Unspecified1 trial

A Study of the Patterns of Use of Etoricoxib in France (MK-0663-148)

Completed·OOrganon and Co··NCT01572675·547 enrolled

Regulatory

FDA Approval Timeline[5]

Dec 31, 1998

CELEBREX

NDA NDA020998

Dec 23, 1999

CELEBREX

NDA NDA020998

Feb 17, 2000

CELEBREX

NDA NDA020998

Mar 21, 2000

CELEBREX

NDA NDA020998

Dec 1, 2000

CELEBREX

NDA NDA020998

Jul 30, 2001

CELEBREX

NDA NDA020998

Aug 15, 2001

CELEBREX

NDA NDA020998

Oct 18, 2001

CELEBREX

NDA NDA020998

Jun 7, 2002

CELEBREX

NDA NDA020998

Aug 29, 2002

CELEBREX

NDA NDA020998

Sep 16, 2002

CELEBREX

NDA NDA020998

Jan 9, 2004

CELEBREX

NDA NDA020998

Feb 9, 2005

CELEBREX

NDA NDA020998

Jul 29, 2005

CELEBREX

NDA NDA020998

Jul 29, 2005

CELEBREX

NDA NDA020998

Dec 15, 2006

CELEBREX

NDA NDA020998

Dec 15, 2006

CELEBREX

NDA NDA020998

Jun 1, 2007

CELEBREX

NDA NDA020998

Nov 2, 2007

CELEBREX

NDA NDA020998

Jan 14, 2008

CELEBREX

NDA NDA020998

Dec 31, 2008

CELEBREX

NDA NDA020998

Feb 4, 2011

CELEBREX

NDA NDA020998

Nov 16, 2012

CELEBREX

NDA NDA020998

Jul 29, 2013

CELEBREX

NDA NDA020998

Jul 28, 2014

CELEBREX

NDA NDA020998

May 9, 2016

CELEBREX

NDA NDA020998

May 9, 2016

CELEBREX

NDA NDA020998

Jun 28, 2018

CELEBREX

NDA NDA020998

May 3, 2019

CELEBREX

NDA NDA020998

May 5, 2020

ELYXYB

NDA NDA212157

Apr 28, 2021

CELEBREX

NDA NDA020998

Nov 21, 2024

CELEBREX

NDA NDA020998

Jul 29, 2025

VYSCOXA

NDA NDA211759

Sources

References

[1]
ClinicalTrials.gov — 413 trial records for Celecoxib. U.S. National Library of Medicine, National Institutes of Health.
[2]
MedlinePlus Drug Information — Celebrex drug information. U.S. National Library of Medicine, National Institutes of Health.
[3]
ChEMBL — Celecoxib compound record. European Bioinformatics Institute (EMBL-EBI).
[4]
Open Targets Platform — Drug–disease associations for Celecoxib. EMBL-EBI & Wellcome Sanger Institute.
[5]
OpenFDA — FDA approval records (NDA NDA211759). U.S. Food & Drug Administration.
[6]
FDA Orange Book — Patent and exclusivity data for Celebrex. U.S. Food & Drug Administration.
[7]
SEC EDGAR — Philadelphia Eye Associates company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Mechanism of Action: Cyclooxygenase-2 Inhibitor[3]
Modality: Small molecule[3]
Highest Phase: Approved[1]
Company: PPhiladelphia Eye Associates

Patent Landscape[6]

Patent Cliff

May 27, 2036

Earliest patent expiration — generic entry possible after this date

Patent #Expires

10722456May 27, 2036

10799517May 27, 2036

9949990May 27, 2036

9795620May 27, 2036

9572819May 27, 2036

2 more patents

10376527May 27, 2036

12678405Sep 16, 2045

Celebrex

Status by Indication[4][1]

Competitive Landscape

Expected Milestones

Q4 2026

Q4 2027

Q1 2028

Trials by Indication[1]

Osteoarthritis19 trials

Celecoxib14 trials

Non-Small Cell Lung Cancer10 trials

Breast Cancer7 trials

Total Knee Arthroplasty5 trials

Colorectal Cancer5 trials

Prostate Cancer3 trials

Ankylosing Spondylitis3 trials

Lung Cancer3 trials

Familial adenomatous polyposis3 trials

Interaction3 trials

Metastatic Colorectal Cancer3 trials

Effectiveness3 trials

Pancreatic Cancer3 trials

Low back pain3 trials

Esophageal Cancer2 trials

Treatment2 trials

Bladder Cancer2 trials

Metabolism2 trials

Liver Cancer2 trials

Chemotherapy2 trials

Schizophrenia2 trials

Multimodal Analgesia2 trials

Acetaminophen2 trials

Head and Neck Cancer2 trials

Post Operative Pain2 trials

Pain Control2 trials

Malignancies2 trials

Aspirin2 trials

Diclofenac1 trial

Myeloproliferative Neoplasm1 trial

Hysterectomy1 trial

Benign Prostatic Hyperplasia1 trial

Colorectal1 trial

Tuberculosis1 trial

Hysteroscopy1 trial

Locally Advanced1 trial

Glioblastoma1 trial

Observational Study1 trial

Germ Cell Tumor1 trial

Opioid Analgesia1 trial

Glioblastoma Multiforme1 trial

Newly Diagnosed1 trial

Antiplatelet1 trial

Premalignant Lesion1 trial

Tics1 trial

Malignant Glioma1 trial

ART1 trial

Pain1 trial

Ewing's Sarcoma1 trial

Weight loss1 trial

Primary Peritoneal Cancer1 trial

Inflammatory Response1 trial

Uterine Cancer1 trial

Bunion1 trial

Blood Pressure1 trial

Pain Management1 trial

Clinical Trial1 trial

Ankle Injuries1 trial

Tonsillectomy1 trial

Preeclampsia1 trial

Sunburn1 trial

Inflammation1 trial

Head and Neck Squamous Cell Carcinoma1 trial

Oral Mucositis1 trial

Basal Cell Carcinoma1 trial

Arthroscopy1 trial

Ovarian Epithelial Cancer1 trial

COVID-191 trial

Multiple Sclerosis1 trial

Bipolar Depression1 trial

Squamous Intraepithelial Lesions of the Cervix1 trial